Correlation Between 37940XAN2 and Abcellera Biologics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both 37940XAN2 and Abcellera Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 37940XAN2 and Abcellera Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GPN 53 15 AUG 29 and Abcellera Biologics, you can compare the effects of market volatilities on 37940XAN2 and Abcellera Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 37940XAN2 with a short position of Abcellera Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of 37940XAN2 and Abcellera Biologics.

Diversification Opportunities for 37940XAN2 and Abcellera Biologics

-0.7
  Correlation Coefficient

Excellent diversification

The 3 months correlation between 37940XAN2 and Abcellera is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding GPN 53 15 AUG 29 and Abcellera Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abcellera Biologics and 37940XAN2 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GPN 53 15 AUG 29 are associated (or correlated) with Abcellera Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abcellera Biologics has no effect on the direction of 37940XAN2 i.e., 37940XAN2 and Abcellera Biologics go up and down completely randomly.

Pair Corralation between 37940XAN2 and Abcellera Biologics

Assuming the 90 days trading horizon GPN 53 15 AUG 29 is expected to generate 0.13 times more return on investment than Abcellera Biologics. However, GPN 53 15 AUG 29 is 7.45 times less risky than Abcellera Biologics. It trades about 0.01 of its potential returns per unit of risk. Abcellera Biologics is currently generating about -0.05 per unit of risk. If you would invest  9,776  in GPN 53 15 AUG 29 on September 2, 2024 and sell it today you would earn a total of  197.00  from holding GPN 53 15 AUG 29 or generate 2.02% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy98.12%
ValuesDaily Returns

GPN 53 15 AUG 29  vs.  Abcellera Biologics

 Performance 
       Timeline  
GPN 53 15 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GPN 53 15 AUG 29 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, 37940XAN2 is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Abcellera Biologics 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Abcellera Biologics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite quite weak fundamental indicators, Abcellera Biologics disclosed solid returns over the last few months and may actually be approaching a breakup point.

37940XAN2 and Abcellera Biologics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with 37940XAN2 and Abcellera Biologics

The main advantage of trading using opposite 37940XAN2 and Abcellera Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 37940XAN2 position performs unexpectedly, Abcellera Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abcellera Biologics will offset losses from the drop in Abcellera Biologics' long position.
The idea behind GPN 53 15 AUG 29 and Abcellera Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Money Managers
Screen money managers from public funds and ETFs managed around the world